On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

Published:2008-06-12 Issue:9 Volume:22 Page:1707-1711
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Feldman E J,Cortes J,DeAngelo D J,Holyoake T,Simonsson B,O'Brien S G,Reiffers J,Turner A R,Roboz G J,Lipton J H,Maloisel F,Colombat P,Martinelli G,Nielsen J L,Petersdorf S,Guilhot F,Barker J,Kirschmeier P,Frank E,Statkevich P,Zhu Y,Loechner S,List A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2008156.pdf

Reference23 articles.

1. Hofmann WK, Koeffler HP . Myelodysplastic syndrome. Annu Rev Med 2005; 56: 1–16.

2. Blinder VS, Roboz GJ . Hematopoietic growth factors in myelodysplastic syndromes. Curr Hematol Rep 2003; 2: 453–458.

3. List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D et al. Efficacy of lenalidomide in myelodysplastic syndromes. NEJM 2005; 352: 549–557.

4. Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimer-Reissig R et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 2002; 20: 2429–2440.

5. Rosenfeld C, List A . A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 2000; 14: 2–8.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

2. Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?;Current Opinion in Oncology;2023-03-17

3. Epidemiology, presentation, and therapeutic approaches for hepatitis D infections;Expert Review of Anti-infective Therapy;2022-12-28

4. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management;American Journal of Hematology;2022-01-27

5. Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials;Expert Opinion on Investigational Drugs;2021-10-01